Contact Us
-
Diet Specialists
Categories
-
Recent Posts
- How Anant Ambani struggled from weight gain due to steroids from asthma treatment – The Times of India
- Usha Chilukuri says hubby Vance adapted her vegetarian diet and learned how to cook Indian food for his mom-in law – The Tribune India
- Instead of crisps, kids could eat snacks from the sea: the forager chef looking to revolutionise Chiles diet – The Guardian
- Banana to mushroom: How a plant-based diet can help you hair and overall well-being – The Times of India
- Is it possible to lose weight in just a few weeks through water fasting? All about the viral weight loss – The Times of India
Archives
Search Weight Loss Topics: |
Category Archives: Testosterone
Testosterone Replacement Therapy Market is on Course to Grow at a CAGR of XX% Over the Forecast Period 2016 2024 – Jewish Life News
Posted: February 14, 2020 at 11:43 am
Testosterone Replacement Therapy market research study in brief
The business intelligence study for the Testosterone Replacement Therapy market provides an extensive synopsis of essential aspects involving the product classification, important definitions, and other industry-specific parameters. The report also covers the key factors associated with the current events such as alliances, mergers & acquisitions, and new product launches.
Additionally, the Testosterone Replacement Therapy market study puts forth a rigid basis for collecting a cluster of insights that potential customers can use to enhance their revenues and reduce costs. The illustration of data on Testosterone Replacement Therapy market segmentation by type, application, and geography offers a critical viewpoint of, what manufacturers are eyeing for the stipulated timeframe, 2019 2026.
This article will help the Testosterone Replacement Therapy vendors understand the volume expansion outlook with impacting trends.
Request Sample Report @ https://www.transparencymarketresearch.co/sample/sample.php?flag=B&rep_id=1097
All of the segments covered in the research study are examined on the basis of BPS, market share, revenue, and other crucial factors. Our business study presents how various segments are adding to the growth of the global Testosterone Replacement Therapy market. It also offers information on key trends with regards to the segments studied in the report. This supports market players to focus on promising regions of the global Testosterone Replacement Therapy market. The research study also delivers independent analysis on the segments as per absolute dollar opportunity.
segmentation includes current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report also covers demand for individual products and applications in all regions.
The report provides the estimated market size of chlorinated paraffins for 2015 and forecast for the next eight years. The global market size of chlorinated paraffins is provided in terms of both volume and revenue. Market volume has been defined in kilo tons, while market revenue is in US$ Mn. Market numbers are estimated based on key products and applications of chlorinated paraffins. Market size and forecast for products and applications have been provided in terms of global and regional markets.
In order to compile the research report, we conducted in-depth interviews and discussions with a number of key industry participants and opinion leaders. Primary research represents the bulk of research efforts, supplemented by extensive secondary research. We reviewed key players product literature, annual reports, press releases, and relevant documents for competitive analysis and market understanding. Secondary research includes a search of recent trade, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise market data, capturing industry participants insights, and recognizing business opportunities.
Secondary research sources that are typically referred to include, but are not limited to company websites, annual reports, financial reports, broker reports, investor presentations, SEC filings, Plastemart magazine, TPE magazine, internal and external proprietary databases, and relevant patent and regulatory databases such as ICIS, Hoovers, oneSOURCE, Factiva and Bloomberg, national government documents, statistical databases, trade journals, market reports, news articles, press releases, and webcasts specific to companies operating in the market.
Primary research involves e-mail interactions, telephonic interviews, and face-to-face interviews for each market, category, segment, and sub-segment across geographies. We conduct primary interviews on an ongoing basis with industry participants and commentators to validate data and analysis. Primary interviews provide firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc. These help validate and strengthen secondary research findings. These also help develop the analysis teams expertise and market understanding.
The report comprises profiles of major companies operating in the global chlorinated paraffins market. Key players profiled in the report include INOVYN, Ajinomoto Fine-Techno Co., Inc., Altair Chimica SpA, NCP Chlorchem, Dover Chemical Corporation, Leuna Tenside GmbH, Qumica del Cinca, Caffaro Industrie S.p.A., JSC Kaustik, KLJ Group, Qualice, LLC, United Group, Makwell Group, and Aditya Birla Chemicals. Market players have been profiled in terms of attributes such as company overview, financial overview, business strategies, and recent developments.
The report segments the global chlorinated paraffins market as follows:
Chlorinated Paraffins Market Product Analysis
Chlorinated Paraffins Market Application Analysis
Chlorinated Paraffins Market Regional Analysis
Limited Time Offer for New Market Entrants to Buy their Copy at a Discounted Rate!!!
Request For Discount On This Report @ https://www.transparencymarketresearch.co/sample/sample.php?flag=D&rep_id=1097
The research attempts to answer many queries such as:
Why Choose Transparency Market Research?
RequestTOC For ThisReport @ https://www.transparencymarketresearch.co/sample/sample.php?flag=T&rep_id=1097
About TMR
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The companys exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMRs experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Contact
Mr. Rohit BhiseyTransparency Market ResearchState Tower90 State Street,Suite 700,Albany, NY 12207United StatesTel: +1-518-618-1030USA Canada Toll Free: 866-552-3453Email: [emailprotected]Website: http://www.transparencymarketresearch.com
Go here to read the rest:
Testosterone Replacement Therapy Market is on Course to Grow at a CAGR of XX% Over the Forecast Period 2016 2024 - Jewish Life News
Posted in Testosterone
Comments Off on Testosterone Replacement Therapy Market is on Course to Grow at a CAGR of XX% Over the Forecast Period 2016 2024 – Jewish Life News
Male Hypogonadism Market to Witness Comprehensive Growth by 2018 2026 – TechNews.mobi
Posted: February 14, 2020 at 11:43 am
Global Male Hypogonadism Market: Brief Account
The global male hypogonadism market is likely to see a steep growth during the forecast period 2018-2028 owing to the rising cases of reduced testosterone level in male all across the world. Hypogonadism is a condition in males where the testes does not function normal. Hypogonadism is caused by the declining rate of biosynthesis of male sex hormones. Rising geriatric population all across the world coupled with rising cases of obesity and rheumatoid arthritis is fueling the growth of the male hypogonadism market during the forecasts period.
The global male hypogonadism market could be classified on the basis of therapy, drug, and disease type. All the segments present in the report could be scrutinized on the basis of its future potential accompanied with the ongoing trends.
Authors of the report have provided a complete overview of the market, thus helping the readers to understand the intricacies of the male hypogonadism market. Authors of the reports have taken help of primary and secondary research which includes information from manufacturers and analysts across the world. This reports helps in taking an important business step.
Get Sample Copy of this report at https://www.marketresearchreports.biz/sample/sample/6439?source=atm
Global Male Hypogonadism Market: Rising Opportunities
The major driving factor behind the global male hypogonadism market is the increasing case of testosterone deficiency among men. Apart from these other factors such as rising infertility rates accompanied with rising awareness among individuals regarding hypogonadism treatment. Government of various countries are helping in rising the awareness about hypogonadism treatment methods, like testosterone replacement therapy is helping to increase the sale of the product in the male hypogonadism market. Rise in prevalence of chronic disorders such as diabetes and obesity is anticipated to boost the growth of the male hypogonadism market.
Apart from these, change in lifestyle, rise in habits such as smoking and drinking coupled with increasing stress levels among males falling under the age range of 25 to 40, leads to reduced estrogen and androgen levels, are favoring the growth of the male hypogonadism market.
However there are certain factors which act as a road block in the growth of the market. High side effects is one of the major restraints that is deterring the growth of the market. It is also expected that the entry of generics would result in sales erosion of leading brands, thus limiting the growth of the market. However, technological advancement is likely to create lucrative opportunities in the market.
Global Male Hypogonadism Market: Geographical Study
Get Discount of this report at https://www.marketresearchreports.biz/sample/checkdiscount/6439?source=atm
On the basis of geography, the global male hypogonadism market is segregated into Europe, North America, Middle East and Africa, and Latin America. Amongst the pack, North America registered the majority share of the market in recent years and is anticipated to hold the leading position during the forecast period. Rise in number of primary and secondary hypogonadism cases accompanied with rising awareness among the males regarding the treatment options is helping the region to lead the market. Apart from these, presence of high tech healthcare sector coupled with technologically advanced product is favoring the region. Asia Pacific is predicted to become the fastest growing market in years to come due to the rise in population accompanied with rise in disposable income.
Global Male Hypogonadism Market: Companies Mentioned
Major players in the market focus on innovation and technologically advanced products to meet the growing demand of the product. Some of the major players in the market are Eli Lilly and Company Ltd., Finox Biotech, Teva Pharmaceutical Industries Ltd., and Bayer AG.
MRR.BIZ has been compiled in-depth market research data in the report after exhaustive primary and secondary research. Our team of able, experienced in-house analysts has collated the information through personal interviews and study of industry databases, journals, and reputable paid sources.
The report provides the following information: Tailwinds and headwinds molding the markets trajectory Market segments based on products, technology, and applications Prospects of each segment Overall current and possible future size of the market Growth pace of the market Competitive landscape and key players strategies
The main aim of the report is to: Enable key stakeholders in the market bet right on it Understand the opportunities and pitfalls awaiting them Assess the overall growth scope in the near term Strategize effectively with respect to production and distribution
MRR.BIZ is a leading provider of strategic market research. Our vast repository consists research reports, data books, company profiles, and regional market data sheets. We regularly update the data and analysis of a wide-ranging products and services around the world. As readers, you will have access to the latest information on almost 300 industries and their sub-segments. Both large Fortune 500 companies and SMEs have found those useful. This is because we customize our offerings keeping in mind the specific requirements of our clients.
Enquiry before buying at https://www.marketresearchreports.biz/sample/enquiryBuy/6439?source=atm
Tags: Male Hypogonadism MarketMale Hypogonadism Market DynamicsMale Hypogonadism Market GrowthMale Hypogonadism Market KeyplayersMale Hypogonadism Market Trends
Go here to see the original:
Male Hypogonadism Market to Witness Comprehensive Growth by 2018 2026 - TechNews.mobi
Posted in Testosterone
Comments Off on Male Hypogonadism Market to Witness Comprehensive Growth by 2018 2026 – TechNews.mobi
Male Hypogonadism to Witness Growth Acceleration During 2018 2028 – Redhill Local Councillors
Posted: February 14, 2020 at 11:43 am
The study on the Male Hypogonadism Market Research delivers a profound comprehension of the market dynamics like drivers, the challenges, trends, and opportunities. The analysis further elaborates on the micro and macro-economic facets which can be predicted to shape the increase of the Male Hypogonadism Market through the forecast period (2019-2029).
The study elucidates the crucial indexes of Male Hypogonadism Market expansion which contains a comprehensive analysis of CAGR development this value series, and Porters Five Forces Analysis. This data may enable readers to realize the growth parameters of this industry that is Male Hypogonadism .
Analytical Insights Contained from the Male Hypogonadism Market Report
Request Sample Report @ https://www.TMRRresearch.com/sample/sample?flag=B&rep_id=1127&source=atm
Male Hypogonadism Market Segmentation Assessment
The increase prospects of this marketplace in several Regions are examined in the report together with details like political, the regulatory frame, and financial prognosis of each region.
Trends and Opportunities
The top driver of the male hypogonadism market includes rising prevalence of testosterone deficiency among men, increasing infertility rates, and increasing awareness among individuals about hypogonadism treatment due to awareness drives organized by several governments across the world. Moreover, high risk of hypogonadism among the geriatric population with obesity and diabetes, and increasing prevalence of chronic disorders among the geriatrics are further expected to boost the markets growth.
However, factors such as high side effects of testosterone products are challenging the growth of testosterone replacement therapy market. Top players in the market are focused on research and development to introduce newer products with fewer or negligible side effects and improved results. For example, LPCN 1111, a product which is under development from Lipocine Inc., is a newer testosterone prodrug that utilizes Lipral technology for enhanced systemic absorption and for enhanced solubility of testosterone. Nevertheless, technological advancements are anticipated to extend new opportunities to the markets growth.
Global Male Hypogonadism Market: Regional Overview
The global male Hypogonadism market can be analyzed with respect to the regional segments of North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. North America held the majority share of the global market in the recent past and is expected to retain its dominant position in the near future. This is mainly due to the rise in the number of individuals suffering from primary and secondary conditions of hypogonadism, and rising awareness among individuals about treatment options for the condition. Moreover, the presence of ultra-modern healthcare infrastructure and increasing popularity of technologically advanced products are expected to offer new opportunities for top players in this market. The region is closely followed by Europe.
Asia Pacific is expected to offer lucrative opportunities to this market due to the modernization of the healthcare infrastructure in the emerging economies of India and China and the increasing awareness about the treatment for the condition. In Asia Pacific, the increasing prevalence of hypogonadism and infertility rates along with the rising geriatric population base with diabetes and obesity are propelling the growth of this market. China, Taiwan, and Malaysia are some of the countries that display the highest rate of male hypogonadism.
Major Companies Mentioned in Report
Some of the key players in the male Hypogonadism market include AbbVie Inc., Astrazeneca plc, Eli Lilly and Company Ltd., Merck & Co. Inc., SA, Finox Biotech, Laboratories Genevrier, Teva Pharmaceutical Industries Ltd., Allergan plc, Bayer AG, Endo International plc, IBSA Institut Biochimque, and Ferring.
Key players are focused on product approval for growth considerations and to cater to the changing demand of the industry. The introduction of innovative and technologically advanced products is also the focus of key players to increase their market share and for serving patients in a better manner.
Request For Discount On This Report @ https://www.TMRRresearch.com/sample/sample?flag=D&rep_id=1127&source=atm
The Report intends to eliminate the subsequent doubts associated with the Male Hypogonadism market economy:
Reasons To Pick TMRR:
Customize This Report @ https://www.TMRRresearch.com/sample/sample?flag=CR&rep_id=1127&source=atm
View original post here:
Male Hypogonadism to Witness Growth Acceleration During 2018 2028 - Redhill Local Councillors
Posted in Testosterone
Comments Off on Male Hypogonadism to Witness Growth Acceleration During 2018 2028 – Redhill Local Councillors
Jatenzo, an Oral Testosterone Replacement Therapy, Now Available – Monthly Prescribing Reference
Posted: February 11, 2020 at 5:42 pm
Jatenzo (testosterone undecanoate; Clarus Therapeutics), an oral testosterone replacement therapy, is now available for the treatment of hypogonadism.
Specifically, Jatenzo is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone:
Jatenzo is not intended for use in males with age-related hypogonadism and its safety and efficacy have not been established in males <18 years old.
The treatment carries a Boxed Warning related to blood pressure (BP) increases that could potentially increase the risk of major adverse cardiovascular events. In a clinical trial, Jatenzo increased systolic BP during 4 months of treatment by an average of 4.9 mmHg based on ambulatory BP monitoring and by an average of 2.8 mmHg from baseline based on BP cuff measurements. For this reason, baseline cardiovascular risk should be considered before initiating therapy and BP should be adequately controlled. Among study patients treated with Jatenzo, 7% were started on antihypertensive medications or required intensification of their antihypertensive medication regimen during the 4-month trial.
Jatenzo, a Schedule III controlled substance, is available in 158mg, 198mg, and 237mg softgels. Dosage should be individualized based on serum testosterone concentrations.
Jatenzo offers patients a convenient softgel formulation, and eliminates the worry of gel transference, skin irritation from patches, or pain from injections that other testosterone treatments carry, said Dr Ronald S. Swerdloff, lead investigator of the inTUne trial, the pivotal study that established the safety and efficacy of the treatment.
For more information visit jatenzo.com.
Go here to see the original:
Jatenzo, an Oral Testosterone Replacement Therapy, Now Available - Monthly Prescribing Reference
Posted in Testosterone
Comments Off on Jatenzo, an Oral Testosterone Replacement Therapy, Now Available – Monthly Prescribing Reference
The Endocrinology Drugs Market is expected to grow by USD 24.78 bn during 2020-2024, progressing at a CAGR of 7% during the forecast period – Yahoo…
Posted: February 11, 2020 at 5:42 pm
Global Endocrinology Drugs Market 2020-2024 The analyst has been monitoring the global endocrinology drugs market and it is poised to grow by USD 24. 78 bn during 2020-2024, progressing at a CAGR of 7% during the forecast period.
New York, Feb. 10, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Endocrinology Drugs Market by Therapy Area and Geography - Forecast and Analysis 2020-2024" - https://www.reportlinker.com/p05849721/?utm_source=GNW Our reports on global endocrinology drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in incidence of endocrine disorders . In addition, association between obesity and endocrine disorders is anticipated to boost the growth of the global endocrinology drugs market as well.
Market Segmentation The global endocrinology drugs market is segmented as below:
Therapy area Diabetes Drugs Thyroid Hormone Disorder Drugs HGH Testosterone Replacement Therapy Others Geographic segmentation North America Europe Asia ROW
Key Trends for global endocrinology drugs market growth This study identifies association between obesity and endocrine disorders as the prime reasons driving the global endocrinology drugs market growth during the next few years.
Prominent vendors in global endocrinology drugs market We provide a detailed analysis of around 25 vendors operating in the global endocrinology drugs market, including some of the vendors such as Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Eli Lilly and Co., GlaxoSmithKline Plc, Groupe Sanofi, Merck & Co. Inc., Novartis International AG, Novo Nordisk AS and Pfizer Inc. .
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Read the full report: https://www.reportlinker.com/p05849721/?utm_source=GNW
About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Story continues
Clare: clare@reportlinker.comUS: (339)-368-6001Intl: +1 339-368-6001
Posted in Testosterone
Comments Off on The Endocrinology Drugs Market is expected to grow by USD 24.78 bn during 2020-2024, progressing at a CAGR of 7% during the forecast period – Yahoo…
Testosterone Replacement Therapy Market Share 2020 In-Depth Analysis of Industry Growth, Trends & Forecast up to 2027 – TechNews.mobi
Posted: February 11, 2020 at 5:42 pm
The Testosterone Replacement Therapy Market Report2020-2027 provides detailed profile assessments and current scenario revenue projections for the most promising industry participants.
The Testosterone Replacement Therapy Market Report gives the different detailed company profiles, product specifications, capacity, production value and market share 2014-2019 for the main suppliers. The Global Testosterone Replacement Therapy Industry Report focuses on the latest trends in global and regional spaces on all important components, including capacity, cost, price, technology, supplies, production, profit, and competition.
For Better Understanding, Download Free Sample Copy of Testosterone Replacement Therapy Market Report In Just One Single Step @ https://www.stratagemmarketinsights.com/sample/8711
The main market players have been identified through secondary research and their market shares have been determined through primary and secondary research. All percentages were divided and breakdowns were determined using secondary sources and verified primary sources.
The following main players are presented in the report: ( AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin, Acerus Pharmaceuticals )
(* Other players can be added on request)
The Testosterone Replacement Therapy Market Report includes the estimation of market size for value (in millions of US dollars) and volume. Top-down and bottom-up approaches were used to estimate and validate the size of the Testosterone Replacement Therapy market, to estimate the size of various other dependent submarkets in the overall market.
The World Testosterone Replacement Therapy Market Report is a professional and in-depth research report on the main regional market conditions of the Testosterone Replacement Therapy industry, focusing on the main regions and countries
North America (USA, Canada and Mexico)Europe (Germany, France, United Kingdom, Russia and Italy)Asia-Pacific (China, Japan, Korea, India and Southeast Asia)South America (Brazil, Argentina, Colombia etc.)Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, Nigeria and South Africa)
Testosterone Replacement Therapy industry development trends and marketing channels are analyzed. Finally, the feasibility of new investment projects is assessed and overall research conclusions are presented.
Table of Contents
Access the full report: https://www.stratagemmarketinsights.com/cart/8711
NOTE: If you have special requirements, please let us know and we will offer you a report as you wish
Posted in Testosterone
Comments Off on Testosterone Replacement Therapy Market Share 2020 In-Depth Analysis of Industry Growth, Trends & Forecast up to 2027 – TechNews.mobi
Murder accused stabbed pub landlord 11 times after he was barred – Liverpool Echo
Posted: February 11, 2020 at 5:42 pm
A man accused of murdering a pub landlord allegedly told police: "You don't need any evidence, I stabbed him to f***."
Lee Abbott knifed dad-of-three Christian Thornton 11 times, after he barred him from the Hammer & Pincers in Widnes.
He stabbed the 49-year-old in the heart and lungs outside the Liverpool Road pub on Sunday, August 11 last year.
Abbott, 35, of Rose Street, Widnes, admits manslaughter but denies murder, in a trial at Liverpool Crown Court.
Jurors today heard Mr Thornton had barred Abbott, then reported him to the police for threatening to burn down his pub.
The landlord later made a report to Widnes PubWatch, which voted to ban Abbott from every pub in the area for a year.
Abbott was informed by letter and went to the Hammer and Pincers at around 3.15pm, armed with a knife in a rucksack.
Opening the trial, David McLachlan, QC, prosecuting, said Mr Thornton, who was practising darts, pushed Abbott outside.
Witnesses described the dad saying "no, get out, you're barred" and telling "very aggravated" Abbott: "Calm down, Lee, go home."
They said Abbott asked "Why am I barred? What have I done?" before pushing him and saying: "You know I would've protected you."
Mr McLachlan said CCTV footage showed Mr Thornton ringing 999 and showing Abbott, who walked away, but then ran at him.
One woman said Mr Thornton shouted "get back" but Abbott pulled out "a f***ing huge kitchen knife" and lunged at him.
We have launched a Facebook group to bring you the latest stories from court all in one place.
It will feature reports from Liverpool Crown Court and elsewhere on Merseyside.
To join and get updates, click here.
A man, who was stood outside, said: "There was no stopping him, he just ran like a mad man.
"He pulled his knife out and stabbed him three, two or three times, turned fell, got up and then fled."
Mr Thornton collapsed and neither paramedics nor a doctor who arrived by helicopter could save his life.
Armed police arrested Abbott when he came out of a friend's house in Ardern, Widnes at 4.22pm, wearing just his boxer shorts.
Mr McLachlan said he told officers "I attacked that Chris, yeah" and added: "You don't need any evidence, I stabbed him to f***."
He said Abbott was taken into custody and said "I've f***ed up here, I know that", then "I'm not a bad person, I've been put in a bad situation."
During police interviews, Abbott said he never had a problem with Mr Thornton, but then described an incident a month beforehand.
Mr McLachlan said Abbott explained he was with a group of men on a ramp outside the pub who were "a bit loud" and "a bit intimidating".
Abbott said he didn't know whether they upset regulars, but Thornton asked them to leave, so he said: "Right, no problem, we'll go."
CCTV showed him speaking to Mr Thornton at the pub on August 2, when they shook hands and the landlord told him he was barred.
The next day, Abbott was filmed "putting his fingers up" to a camera, then "head to head" with Mr Thornton in the beer garden, when Mr McLachlan said he threatened to burn the pub down.
However, when Mr Thornton reported him to police, he said he didn't want any formal action being taken against him, but for the incident to be logged and officers to tell him he was barred.
Two days after a Widnes PubWatch meeting on August 6, Halton Council wrote to Abbott to inform him of the 12-month ban.
On August 11, Abbott caught a taxi from his girlfriend Danielle Hayes' home to Liverpool Road, carrying his rucksack by hand as he entered the pub.
Abbott told police he tried to explain to Mr Thornton he got the group to leave in the prior incident, but the landlord "wasn't having any of it" and it became "a little bit heated".
He said when Mr Thornton got his phone out and rang 999, he ran back towards him and started stabbing him.
Abbott said: "I just panicked I didnt know what to do, I just, I just saw red and just lost it and I just... I just come down and I just pulled the knife, pulled the knife and just, and just, obviously what youve just seen on that, on, on the CCTV, I just, I just didn't, I just lost it completely."
He added: "It was so fast it was like red mist, I didn't know exactly, I couldn't recall exactly what had gone on."
Abbott accepted previously threatening Mr Thornton, saying he wouldn't have a pub if he carried on, because he was "p***ed off", which was "a daft thing to say".
However, he said he couldn't believe it when Mr Thornton tried to get him barred from every pub, which was "a bit personal".
Mr McLachlan said Abbott told police he was "really upset", had been drinking all day and was "angry".
He also said he suffered from depression and was taking testosterone replacement therapy because he had a blood disorder called haemochromatosis, which 'crashed' his hormones, and affected his mood and stability.
Police recovered the blade used to stab Mr Thornton at the scene, which had snapped in two, and the handle in Abbott's rucksack, at his friend's house.
He said he took both the knife and rucksack from his girlfriend's house because he was annoyed, and when asked why, replied: "I've no idea, I don't know what I was thinking."
Abbott accepted threatening to burn the pub down and said that when drinking: "It does send me, it sends me a little bit... a little bit nasty."
He said: "I just lost it by that point, completely lost it" and added: "I just stabbed him, I was in a, just a rage, I wasn't in control... it's scary."
However, he said: "I just saw red... obviously knew I was gonna hurt him, I knew I was gonna stab him I didn't think for one minute 'I want to kill him'."
Tests revealed Abbott was an estimated three and a half times over the drink drive limit during the attack and had cocaine and testosterone in his system.
Mr McLachan said Abbott believed it was "an injustice" when he was barred, and armed himself with a knife because he intended to either kill or inflict really serious harm on the landlord.
He said: "And what did Lee Abbott do? He stabbed and he stabbed Christian Thornton to death in broad daylight on an early Sunday afternoon."
Mr McLachlan said prosecutors understood Abbott would argue it wasn't murder because he didn't have the necessary intent, due to being "heavily intoxicated", and would rely on the partial defence of diminished responsibility due to "an abnormality of mental functioning".
Mr McLachlan said: "We do not accept either of these defences and will assert that this is simply a case of murder.
"Murder pure and simple, where a man knows what he did, he took a knife to the scene, and he stabbed somebody 11 times."
(Proceeding)
View original post here:
Murder accused stabbed pub landlord 11 times after he was barred - Liverpool Echo
Posted in Testosterone
Comments Off on Murder accused stabbed pub landlord 11 times after he was barred – Liverpool Echo
Testosterone Replacement Therapy Market is poised to achieve continuing growth During Forecast Period 2020-2026 – Jewish Life News
Posted: February 10, 2020 at 7:46 am
Global Marketers.biz has published an innovative statistics of the market titled as Testosterone Replacement Therapy Market. To clarify the various aspects, the analyst studies and elaborates the terms by using qualitative and quantitative research techniques. Finance teams can use a variety of corporate planning applications to fulfil the budgeting, planning & financial modelling, needs of their organization, whatever its size, industry and location.
Download Exclusive Sample of Testosterone Replacement Therapy Markets Premium Report at: https://www.globalmarketers.biz/report/life-sciences/global-testosterone-replacement-therapy-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/129647 #request_sample
Graphs, tables, bar graphs and pie charts have been represented in sophisticate manner for the clients to better understand the analysis. To enlarge the businesses, customers get increased rapidly through Testosterone Replacement Therapy industry techniques.
Leading Establishments (Key Companies): AbbVieEndo InternationalEli lillyPfizerActavis (Allergan)BayerNovartisTevaMylanUpsher-SmithFerring PharmaceuticalsKyowa KirinAcerus Pharmaceuticals
Different regions, such as Americas, United States, Canada, Mexico, Brazil, APAC, China, Japan, Korea, Southeast Asia, India, Australia, Europe, Germany, France, UK, Italy, Russia, Spain, Middle East & Africa, Egypt, South Africa, Israel, Turkey and GCC Countries are focused to give the summarized data about the production of Testosterone Replacement Therapy market.
The global Testosterone Replacement Therapy Market is served as a backbone for the enlargement of the enterprises. To address the challenges, the report examines different key factors such as drivers and opportunities. Restraints are considered for evaluation of risk in market.
Segments covered in the report
This report forecasts revenue growth at a global, regional & country level, and analyses the market trends in each of the sub-segments from 2015 to 2026. For the purpose of this study, Global Marketers.biz have segmented the Testosterone Replacement Therapy market on the basis of type, end-user and region:
Inquiry Here For Detail Report @ https://www.globalmarketers.biz/report/life-sciences/global-testosterone-replacement-therapy-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/129647 #inquiry_before_buying
Type Outlook (Revenue in Million USD; 20152026)
GelsInjectionsPatchesOther
End Use Outlook (Revenue in Million USD; 20152026)
HospitalsClinicsOthers
Testosterone Replacement Therapy Market Summary: This report includes the estimation of market size for value (million US$) and volume. Estimation methodology validate the market size of Testosterone Replacement Therapy industry, to estimate the size of various other dependent submarkets in the overall market. Secondary research is used to identify the top players in the market, and their market shares have been determined through primary and secondary research. Each type is studied based on classification as Sales, Testosterone Replacement Therapy Market Share (%), Revenue (Million USD), Price and Gross Margin.
Report Objectives:
Target Audience:
Table of Content:
To know More Details About Testosterone Replacement Therapy Market research Report @: https://www.globalmarketers.biz/report/life-sciences/global-testosterone-replacement-therapy-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/129647 #table_of_contents
***Thanks for reading! You can also request custom information like chapter-wise or specific region-wise study as per your interest. ***
Continued here:
Testosterone Replacement Therapy Market is poised to achieve continuing growth During Forecast Period 2020-2026 - Jewish Life News
Posted in Testosterone
Comments Off on Testosterone Replacement Therapy Market is poised to achieve continuing growth During Forecast Period 2020-2026 – Jewish Life News
The Global Endocrinology Drugs Market is expected to grow by USD 24.78 bn during 2020-2024, progressing at a CAGR of 7% during the forecast period -…
Posted: February 9, 2020 at 5:44 pm
Global Endocrinology Drugs Market 2020-2024 The analyst has been monitoring the global endocrinology drugs market and it is poised to grow by USD 24. 78 bn during 2020-2024, progressing at a CAGR of 7% during the forecast period.
New York, Feb. 04, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Endocrinology Drugs Market 2020-2024" - https://www.reportlinker.com/p03793964/?utm_source=GNW Our reports on global endocrinology drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in incidence of endocrine disorders. In addition, association between obesity and endocrine disorders is anticipated to boost the growth of the global endocrinology drugs market as well.
Market Segmentation The global endocrinology drugs market is segmented as below: Therapy area Diabetes Drugs Thyroid Hormone Disorder Drugs HGH Testosterone Replacement Therapy Others
Geographic segmentation North America Europe Asia ROW
Key Trends for global endocrinology drugs market growth This study identifies association between obesity and endocrine disorders as the prime reasons driving the global endocrinology drugs market growth during the next few years. Prominent vendors in global endocrinology drugs market We provide a detailed analysis of around 25 vendors operating in the global endocrinology drugs market, including some of the vendors such as Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Eli Lilly and Co., GlaxoSmithKline Plc, Groupe Sanofi, Merck & Co. Inc., Novartis International AG, Novo Nordisk AS and Pfizer Inc. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.Read the full report: https://www.reportlinker.com/p03793964/?utm_source=GNW
About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Clare: clare@reportlinker.comUS: (339)-368-6001Intl: +1 339-368-6001
Posted in Testosterone
Comments Off on The Global Endocrinology Drugs Market is expected to grow by USD 24.78 bn during 2020-2024, progressing at a CAGR of 7% during the forecast period -…
Testosterone Replacement Therapy Market- Revenue, Research Till 2026 Industry Influence Over Market – Reporting 99
Posted: February 8, 2020 at 8:45 am
The goal of Global Testosterone Replacement Therapy market research report is to provide the users a complete picture of the Testosterone Replacement Therapy market during the forecast period from 2020-2026 The global Testosterone Replacement Therapy market report provides the key market insights and the growth-inducing factors. It also does the comprehensive study of Testosterone Replacement Therapy Industry based on market gains, market volume, key industry sections of Testosterone Replacement Therapy which are differentiated based on product type, product application, major geographical regions contributing to the development of Testosterone Replacement Therapy market.
Get FREE Sample Report Copy @ https://www.globalmarketers.biz/report/business-services/2018-global-testosterone-replacement-therapy-industry-research-report/118104 #request_sample
Global Testosterone Replacement Therapy Market Analysis By Major Players:
AbbviePfizerEli LillyTeva PharmaceuticalsMylanBayer Healthcare PharmaceuticalsAntares PharmaFerring PharmaceuticalsAllerganAntares PharmaSandozClarus TherapeuticsJuniper PharmaceuticalsEndo InternationalAcerus PharmaceuticalsForendo PharmaMetp PharmaRepros Therapeutics
Global Testosterone Replacement Therapy market enlists the vital market events like Testosterone Replacement Therapy product releases, technical developments and groundbreaking market schemes of Testosterone Replacement Therapy which will help the readers to identify opportunities and risk factors which affect the development. Worldwide Testosterone Replacement Therapy market report covers chief market segments based on product type, product application, potential users and key zones.
Advantages Of The Global Testosterone Replacement Therapy Market Report:
Extensive analysis based on market segments will enhance the Testosterone Replacement Therapy market growth
Analysis of Testosterone Replacement Therapy market key player and their business tactics will help in making important business decisions
Testosterone Replacement Therapy Market Technological advancements will fuel the growth of global market
Region-wise analysis and emerging segment analysis of Testosterone Replacement Therapy market will provide clear view of global market
Testimonials to companies will provide concrete and better control over the Testosterone Replacement Therapy market
This Testosterone Replacement Therapy report analyzes the global market by the following segments:
By Product Types:
GelsInjectablesPatchesOther
By Product Applications:
HospitalsClinicsOther
Analysis By Geographical Zones:
Europe (Germany, France, Italy, Russia and UK)
North (Canada, USA and Mexico)
Latin America (Middle and Africa)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Asia-Pacific (South-east Asia, China, India, Korea and Japan)
Inquiry Here For Detail Report @ https://www.globalmarketers.biz/report/business-services/2018-global-testosterone-replacement-therapy-industry-research-report/118104 #inquiry_before_buying
Following 15 elements represents the Testosterone Replacement Therapy market globally:
Element 1, enlist the goal of global Testosterone Replacement Therapy market covering the market introduction, product image, market summary, development scope, Testosterone Replacement Therapy market presence;
Element 2, studies the key global Testosterone Replacement Therapy market competitors, their sales volume, market profits and price of Testosterone Replacement Therapy in 2015 and 2020;
Element 3, shows the competitive landscape view of global Testosterone Replacement Therapy market on the basis of dominant market players and their share in the market growth in 2015 and 2020;
Element 4, conducts the region-wise study of the global Testosterone Replacement Therapy market based on the sales ratio in each region, and market share from 2015 to 2020;
Element 5,6,7,8 and 9 demonstrates the key countries present in these regions which have revenue share in Testosterone Replacement Therapy market;
Element 10 and 11 describes the market based on Testosterone Replacement Therapy product category, wide range of applications, growth based on market trend, type and application 2015 to 2020;
Element 12 shows the global Testosterone Replacement Therapy market plans during the forecast period from 2020 to 2026 separated by regions, type, and product application.
Element 13, 14, 15 mentions the global Testosterone Replacement Therapy market sales channels, market vendors, dealers, market information and study conclusions, appendix and data sources.
Explore Full Report With Detailed TOC Here @ https://www.globalmarketers.biz/report/business-services/2018-global-testosterone-replacement-therapy-industry-research-report/118104 #table_of_contents
Posted in Testosterone
Comments Off on Testosterone Replacement Therapy Market- Revenue, Research Till 2026 Industry Influence Over Market – Reporting 99